Updated 24 September 2026. Whoopi Goldberg has spoken publicly about using Mounjaro (tirzepatide) while discussing her weight and health on The View. Her comments are useful as an example of how prescription weight-management medicines have entered mainstream conversation—but one celebrity’s experience should not be treated as a treatment plan for anyone else.
Earlier coverage of Whoopi Goldberg’s comments framed Goldberg’s story as a transformation narrative and presented Mounjaro as though her result demonstrated how the medicine should work for readers. That was too simplistic. Weight-management medicines require clinical assessment, have side effects and eligibility criteria, and work within a broader programme of care.
This updated article separates what Goldberg has actually said from what UK readers need to know about tirzepatide in 2026.
What Whoopi Goldberg actually said
In March 2024, Goldberg said on The View that she had used Mounjaro and that it had helped her lose weight after she had reached close to 300 lb while making the film Till. Reporting on her comments also noted that she linked part of her previous weight gain to illness, hospital treatment and steroid use. You can read the People report summarising Goldberg’s March 2024 comments.
Those are her own public statements. BetterCare cannot independently verify a complete medical history, exact dosing, duration of treatment or every factor that affected her weight.
That distinction matters. Celebrity health stories often compress years of medical, psychological and lifestyle context into a headline such as “how she lost the weight”. Real treatment is rarely that simple.
Goldberg’s story is not evidence that everyone should use Mounjaro
A personal account can describe what happened to one person. It cannot tell another person whether a medicine is appropriate, what dose they need, how much weight they will lose or which side effects they may experience.
Tirzepatide is a prescription medicine. In the UK, the NHS describes tirzepatide, commonly sold as Mounjaro, as a medicine used to manage type 2 diabetes or obesity. It is available only on prescription.
For weight management, it is used alongside changes to diet and physical activity rather than as a stand-alone replacement for them.
How tirzepatide works
Tirzepatide acts on two hormone-receptor pathways: GIP and GLP-1. These pathways are involved in appetite, blood-glucose regulation and digestion.
For weight management, the medicine can reduce appetite and help people feel fuller for longer. That can make it easier for some people to maintain a reduced energy intake.
This is a pharmacological treatment, not simply an appetite “hack”. The drug has defined dosing, contraindications, side effects and clinical monitoring requirements.
Mounjaro is not just a celebrity weight-loss product
Social-media discussion can make medicines such as tirzepatide look like cosmetic treatments. UK guidance places them inside obesity and diabetes care.
NHS England’s current information on weight-management injections explains that tirzepatide is recommended for certain eligible patients living with obesity and weight-related health problems.
Access through the NHS is being introduced in phases and depends on clinical need and eligibility. Private prescribing also requires assessment by an appropriate prescriber.
Who may be eligible in the UK?
Eligibility is not based on celebrity use or on wanting to lose a small amount of weight quickly.
NICE and NHS pathways use criteria that consider BMI and weight-related health conditions. NHS England has been rolling access out in stages, prioritising people with the highest clinical need.
Criteria can also differ depending on whether treatment is delivered through specialist services or primary care.
If you want to know whether tirzepatide is appropriate for you, the correct route is a GP, specialist weight-management service or legitimate private prescriber—not an online seller promising instant access.
The medicine is part of wraparound care
NHS England requires structured support alongside tirzepatide when it is prescribed for obesity in primary care. This includes clinical follow-up and behavioural support.
The NHS England guidance on tirzepatide wraparound care makes clear that regular clinical review and behavioural support are essential treatment components.
That is very different from the idea of simply ordering an injection and managing the rest alone.
What side effects can occur?
The NHS lists common side effects of tirzepatide including nausea, vomiting, constipation, diarrhoea, stomach pain, tiredness, injection-site reactions and hair loss.
Not everyone experiences these effects, and severity varies. Persistent or concerning symptoms should be discussed with the prescribing clinician or pharmacist.
People should not change doses, combine medicines or stop treatment suddenly without appropriate advice, especially when tirzepatide is being used to manage type 2 diabetes.
Pregnancy, contraception and HRT require particular attention
Tirzepatide is not recommended during pregnancy or when planning pregnancy, and it is not recommended while breastfeeding.
The NHS also advises additional barrier contraception for four weeks after starting tirzepatide and for four weeks after each dose increase when someone uses the contraceptive pill, because absorption may be affected.
People using oral HRT are also advised to discuss alternative delivery methods such as patches or gels with a clinician.
These are examples of why a celebrity story cannot substitute for individual prescribing advice.
What about buying Mounjaro online?
The NHS warns that fake weight-loss medicines are sold online. If obtaining a private prescription, use a registered pharmacy and a legitimate prescriber.
A seller that offers prescription injections without meaningful health questions, medical oversight or follow-up is a serious warning sign.
Do not buy unlabelled pens, share prescription medicine or use products supplied through social-media accounts.
Goldberg has also warned about fake advertising using her image
In 2025, Goldberg publicly warned about an AI-generated advertisement that used manipulated footage of her to promote weight-loss products she had not endorsed. Reporting on her warning described the advertisement as unauthorised and misleading.
This matters for readers because celebrity images are increasingly used to sell supplements, compounded products and unverified treatments.
If an advertisement claims that a celebrity “secretly used” or endorses a product, verify the claim through the person’s own public statements or a reputable source before believing it.
Why celebrity weight stories can be misleading even when the facts are true
A headline may accurately report that someone used a medicine while still leaving out important context:
- their complete medical history;
- other medicines they were taking;
- how long treatment lasted;
- what dietetic or clinical support they received;
- side effects;
- changes in activity, appetite or health;
- whether the medicine is still being used;
- what happened after treatment changed.
That missing context makes direct comparison with your own body unreliable.
Weight stigma should not drive medical decisions
Goldberg has also discussed the judgement people experience around body weight and medication. That aspect of the conversation is important.
Obesity is not adequately explained by willpower alone. Biology, environment, medicines, illness, sleep, mental health, food availability and activity can all contribute.
At the same time, recognising obesity as a complex condition does not mean every person in a larger body needs medication. Treatment decisions should be based on health, preferences and clinical need.
What should a UK reader do if they are interested in tirzepatide?
Start with a proper assessment. Useful questions include:
- Do I meet the eligibility criteria for obesity treatment?
- Do I have weight-related conditions that change treatment options?
- Could another medicine or health condition be affecting my weight?
- What are the likely benefits and side effects for me?
- What happens if I stop treatment?
- How will diet, activity and behavioural support be integrated?
- How will progress and side effects be monitored?
A good consultation should answer those questions rather than focusing only on how much weight you might lose.
What if you do not qualify for medication?
Not qualifying for tirzepatide does not mean there are no treatment options.
Depending on your circumstances, support may include dietary intervention, physical-activity support, behavioural programmes, management of sleep or mental-health issues, other prescription medicines or specialist weight-management services.
The appropriate route depends on health status and clinical need.
Do not compare your result with a celebrity’s number
Weight change differs substantially between individuals. A person starting at a higher body weight may lose more kilograms while experiencing a similar percentage change to someone lighter.
Clinical trials report averages, not guarantees. Some people respond strongly, some more modestly, and some discontinue because of side effects or other reasons.
The goal of treatment is not to reproduce a celebrity’s before-and-after story. It is to improve health in a way that is safe and sustainable for the individual.
Questions that come up around Whoopi Goldberg and Mounjaro
Did Whoopi Goldberg say she used Mounjaro?
Yes. In March 2024, Goldberg publicly said that Mounjaro was one of the things that helped her lose weight after she had reached close to 300 lb while making Till.
Is Mounjaro approved for weight loss in the UK?
Tirzepatide is licensed and used in the UK for obesity management as well as type 2 diabetes, subject to prescribing criteria and clinical assessment.
Can anyone get Mounjaro on the NHS?
No. NHS access is based on eligibility and is being introduced in phases, with priority given to people with higher clinical need.
Is Mounjaro the same as Ozempic?
No. Mounjaro contains tirzepatide and acts on GIP and GLP-1 receptors. Ozempic contains semaglutide and is a GLP-1 receptor agonist. They are different prescription medicines.
Can I buy tirzepatide online?
Private prescribing can be legitimate, but it should involve a registered prescriber and pharmacy. Avoid unregulated sellers or products marketed through social media without clinical oversight.
Will Mounjaro work the same way for me as it did for Whoopi Goldberg?
No one can assume that. Individual responses, side effects, medical history and treatment duration vary.
What Goldberg’s story can and cannot tell us
Whoopi Goldberg’s public comments confirm that she used Mounjaro and felt it helped her lose weight. That is a personal account, not a clinical recommendation.
For UK readers in 2026, tirzepatide is a regulated prescription treatment used for type 2 diabetes and obesity in appropriate patients. It requires assessment, monitoring and wider support.
The most useful lesson from a celebrity story is not “copy what they did”. It is to separate verified statements from speculation and understand the medical treatment in its proper context.
Public-figure medication context: This article reports public statements and provides general UK health information. It does not diagnose obesity or recommend tirzepatide for an individual.
